Pharmacokinetics and Safety of ALKS 5461 in Healthy Subjects and Subjects With Hepatic Impairment and Normal Hepatic Function

Completed · Phase 1

Conditions studied: Hepatic Impairment

In brief

This study will evaluate the effect of various degrees of hepatic function on the pharmacokinetics and safety of ALKS 5461.

Key facts

Study ID
NCT02452801
Run by
Alkermes, Inc.
People needed
40
Starts
2015-05-01
Expected to finish
2015-12-01
Last updated by the study team
2016-02-04

Who can join

Age: 18 and older, up to 70. Sex: any. Healthy volunteers: accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.